[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355509-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355509-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","il-24-amplifies-baicalein-induced-immunogenic-cell-death-in-ovarian-cancer-by-boosting-endoplasmic-reticulum-stress","IL-24 amplifies baicalein-induced immunogenic cell death in ovarian cancer by boosting endoplasmic reticulum stress","","Ovarian cancer remains a major cause of gynecologic cancer mortality, creating demand for novel immunomodulatory approaches. Immunogenic cell death (ICD) can enhance antitumor immunity, yet baicalein’s ability to trigger ICD in ovarian cancer and the responsible molecular pathways were unclear. Using murine and human ovarian cancer models, the study evaluates ICD hallmarks and immune activation, and applies transcriptomic methods to probe endoplasmic reticulum stress signaling and IL-24 induction.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/il-24-amplifies-baicalein-induced-immunogenic-cell-death-in-ovarian-cancer-by-boosting-endoplasmic-reticulum-stress/355509/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/il-24-amplifies-baicalein-induced-immunogenic-cell-death-in-ovarian-cancer-by-boosting-endoplasmic-reticulum-stress/355509.png","ImageObject",300,407,{"name":42,"@type":43},"Jordan Avery","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the primary goal of the study?","Question",{"text":63,"@type":64},"To determine whether baicalein can promote immunogenic cell death in ovarian cancer and to clarify the underlying molecular mechanisms, focusing on IL-24 and ER stress.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which ICD hallmarks were assessed after baicalein treatment?",{"text":68,"@type":64},"The study evaluated calreticulin (CRT) exposure, extracellular ATP and HMGB1 release, and the induction of pro-inflammatory cytokines.",{"name":70,"@type":61,"acceptedAnswer":71},"How did the researchers test immune activation?",{"text":72,"@type":64},"They assessed dendritic cell maturation and measured T cell responses in vitro and in vivo using dendritic cell experiments and T cell priming assays.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355509,1790698615,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Yang et al. Journal of Ovarian Research (2026) 19:154 Journal of Ovarian Research  \n[https://doi.org/10.1186/s13048-025-01953-3](https://doi.org/10.1186/s13048-025-01953-3)  \nRESEARCH Open Access  \nIL-24 amplifies baicalein-induced immunogenic cell death in ovarian cancer by boosting endoplasmic reticulum stress  \nJie Yang1,2,3†, Feima Wu1†, Biling Zhong1, Yexin Liu1, Qiao Yuan3, Guimin Wang1, Jianbin Zhou2* and Hui Peng1*  \nAbstract  \nBackground Ovarian cancer (OC) remains a leading cause of gynecologic cancer mortality worldwide, highlighting the need for novel immunomodulatory therapies. Immunogenic cell death (ICD) has emerged as a promising strategy to enhance antitumor immunity in OC. Baicalein, a bioactive flavonoid with documented anticancer activity across diverse tumor types, has not been comprehensively assessed for its potential to induce ICD in OC. This study aimed to explore baicalein’s ability to promote ICD and elucidate the underlying molecular mechanisms.  \nMethods Both murine (ID8) and human (SKOV3) ovarian cancer cell lines were used to examine the cytotoxic and immunogenic effects of baicalein. Cell viability and apoptosis were evaluated using CCK-8 assays and flow cytometry. ICD hallmarks, including surface calreticulin (CRT) exposure, extracellular ATP and HMGB1 release, as well as the induction of pro-inflammatory cytokines, were systematically evaluated in cells treated with baicalein. The functional impact on immune activation was assessed in vitro using dendritic cells and in vivo via T cell priming assays. RNAsequencing and RT-PCR were used to explore underlying molecular pathways, including endoplasmic reticulum (ER) stress signaling and IL-24 induction.  \nResults We found that OC cells treated with baicalein showed increased ICD features, including CRT exposure, extracellular release of ATP and HMGB1, and increased expression of IFNβ and CXCL10 . Functionally, baicalein-treated OC cells promoted dendritic cell maturation and stimulated CD4⁺ and CD8⁺ T cell responses in vivo. Transcriptomic analysis revealed activation of ER stress pathways, particularly the ATF3/CHOP/DR5 axis. Inhibition of ER stress or reactive oxygen species (ROS) attenuated baicalein-induced ICD, suggesting a ROS-dependent mechanism. Notably, baicalein markedly upregulated IL-24 expression in an ER stress-dependent manner and IL-24 further enhanced baicalein-induced ER stress and ICD features.  \nConclusion This study reveals that BAI induces IL-24 expression through ER stress, with IL-24 subsequently reinforcing BAI-mediated ER stress and potentiating ICD in ovarian cancer. These findings support the therapeutic potential of BAI as an ICD inducer and immunomodulatory agent in ovarian cancer.  \n†Jie Yang and Feima Wu contributed equally to this work.  \n*Correspondence: Jianbin Zhou [546612589@qq.com](546612589@qq.com)[ ](546612589@qq.com)Hui Peng [hpeng392@163.com](hpeng392@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, vis","cbCaikj6f9DyrcXk","https://ap.wps.com/l/cbCaikj6f9DyrcXk","pdf",2800056,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Keywords","[{\"question\":\"What was the primary goal of the study?\",\"answer\":\"To determine whether baicalein can promote immunogenic cell death in ovarian cancer and to clarify the underlying molecular mechanisms, focusing on IL-24 and ER stress.\"},{\"question\":\"Which ICD hallmarks were assessed after baicalein treatment?\",\"answer\":\"The study evaluated calreticulin (CRT) exposure, extracellular ATP and HMGB1 release, and the induction of pro-inflammatory cytokines.\"},{\"question\":\"How did the researchers test immune activation?\",\"answer\":\"They assessed dendritic cell maturation and measured T cell responses in vitro and in vivo using dendritic cell experiments and T cell priming assays.\"}]","IL-24 amplifies baicalein-induced immunogenic cell death in ovarian cancer by boosting endoplasmic reticulum stress | PDF",1790119541,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1489bd991714060a61d8ea1e4f10ee73.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f53d8d6462540da6a1c96947ba12723.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b5e77bb8f1fd82b5d1cb8b20e829829.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9eeb3687a84069cdfbd941e08095a44d.webp",980,1306]